Zymeworks
Chayne Piscitelli is a Principal Scientist and Group Lead in Protein Engineering at Zymeworks Inc. They have extensive experience in engineering and developing antibody-based cancer therapeutics, specifically focusing on multi-specific immune cell engager platforms. Prior to their current role, they worked as a Postdoctoral Research Fellow at ETH Zürich and Paul Scherrer Institute, and as a Ph.D. Research Assistant at Oregon Health & Science University. Chayne’s educational background includes a Ph.D. in Biochemistry from Oregon Health & Science University and a Bachelor of Science in Chemistry from Montana State University-Bozeman. Their research experience ranges from X-ray crystallographic methods to water quality analyses.
Zymeworks
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.